Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
Add more filters










Publication year range
1.
J Pharmacol Exp Ther ; 310(3): 1171-82, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15178694

ABSTRACT

SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one] is a new, nonselective, and reversible monoamine oxidase (MAO) inhibitor, belonging to a oxazoloquinolinone series. In vitro studies showed that SL25.1131 inhibits rat brain MAO-A and MAO-B with IC50 values of 6.7 and 16.8 nM and substrate-dependent Ki values of 3.3 and 4.2 nM, respectively. In ex vivo conditions, the oral administration of SL25.1131 induced a dose-dependent inhibition of MAO-A and MAO-B activities in the rat brain with ED50 values of 0.67 and 0.52 mg/kg, respectively. In the rat brain, duodenum, and liver, the inhibition of MAO-A and MAO-B by SL25.1131 (3.5 mg/kg p.o.) was reversible, and the recovery of MAO-A and MAO-B activities was complete 16 h after administration. SL25.1131 (3.5 mg/kg p.o.) increased tissue levels of dopamine (DA), norepinephrine, and 5-hydroxytryptamine and decreased levels of their deaminated metabolites 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindolacetic acid. In mice, SL25.1131 induced a dose-dependent potentiation of 5-hydroxytryptophan-induced tremors and phenylethylamine-induced stereotypies with ED50 values of 0.60 and 2.8 mg/kg p.o., respectively. SL25.1131 was able to reestablish normal striatal dopaminergic tone and locomotor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mice. In addition, when coadministered with L-DOPA, SL25.1131 increased the available DA in the striatum and the duration of L-DOPA-induced hyperactivity. The duration of the effect of L-DOPA on circling behavior in 6-hydroxydopamine-lesioned rats was also increased. The neurochemical profile of SL25.1131 demonstrates that this compound is a mixed, potent, and reversible MAO-A/B inhibitor in vitro, in vivo, and ex vivo. SL25.1131 has therapeutic potential as a symptomatic treatment during the early phase of Parkinson's disease and as an adjunct to L-DOPA therapy during the early and late phases of the disease.


Subject(s)
Maze Learning/drug effects , Monoamine Oxidase Inhibitors/pharmacology , Monoamine Oxidase/metabolism , Nervous System Diseases/metabolism , Oxazoles/pharmacology , Quinolines/pharmacology , 3,4-Dihydroxyphenylacetic Acid/metabolism , Animals , Benzophenones/pharmacology , Brain/drug effects , Brain/enzymology , Corpus Striatum/drug effects , Corpus Striatum/metabolism , Disease Models, Animal , Dopamine/metabolism , Drug Interactions , Levodopa , MPTP Poisoning/metabolism , Mice , Mice, Inbred C57BL , Monoamine Oxidase Inhibitors/therapeutic use , Nervous System Diseases/chemically induced , Nervous System Diseases/drug therapy , Nitrophenols , Oxazoles/therapeutic use , Oxidopamine , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Quinolines/therapeutic use , Rats , Rats, Sprague-Dawley , Serotonin/metabolism , Stereotyped Behavior/drug effects , Tolcapone , Tremor/chemically induced , Tremor/drug therapy , Tyramine/pharmacology
2.
Eur J Neurosci ; 12(1): 322-36, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10651887

ABSTRACT

We have examined the behavioural consequences of a partial unilateral dopaminergic denervation of the rat striatum. This partial lesion was obtained by an intrastriatal 6-hydroxy-dopamine injection (6-OHDA, 20 or 10 microgram divided between two injection sites) and was compared with a unilateral complete lesion resulting from an injection of 6-OHDA (2 x 6 microgram) into the medial forebrain bundle. Quantification of striatal dopamine (DA) and its metabolites, and the immunohistochemical evaluation of the nigrostriatal DA system confirmed the complete and partial lesions. Animals with complete striatal denervation displayed both apomorphine- and amphetamine-induced rotations whereas the partial denervation elicited amphetamine-induced rotations only. However, the rates of amphetamine-induced rotation were not correlated with the size of the lesion. In contrast, the paw-reaching impairments were significantly correlated with the striatal dopaminergic depletion. When evaluated in the staircase test, animals with partial denervation were impaired exclusively for the paw contralateral to the side of the lesion. This motor deficit (50-75%) included all components of the skilled paw use (i.e. attempt, motor coordination and success) and was observed at least 12 weeks after the lesion. However, these animals were able to perform normal stepping adjustments with the impaired paw, indicating that the partial lesion induced a coordination deficit of the paw rather than a deficit of movement initiation. After a complete lesion, stepping adjustments of the contralateral paw were dramatically impaired (by 80%), an akinesia which almost certainly accounted for the great deficit in skilled paw use. The paw-reaching impairments resulting from the partial striatal denervation are proposed as a model of the early symptoms of Parkinson's disease and may be useful for the development of restorative therapies.


Subject(s)
Corpus Striatum/physiology , Dopamine/metabolism , Motor Activity/physiology , Psychomotor Performance/physiology , Amphetamine/pharmacology , Animals , Apomorphine/pharmacology , Corpus Striatum/drug effects , Corpus Striatum/pathology , Denervation , Female , Forelimb/innervation , Functional Laterality , Gait/drug effects , Gait/physiology , Motor Activity/drug effects , Oxidopamine/toxicity , Posture/physiology , Psychomotor Performance/drug effects , Rats , Rotation
3.
Brain Res ; 840(1-2): 162-6, 1999 Sep 04.
Article in English | MEDLINE | ID: mdl-10517965

ABSTRACT

Neuronal survival is influenced by the redox environment, and it has been shown that antioxidants protect developing neurons from the effects of axotomy. Here, we show that the intraocular injection of salicylic acid (SA) reduces the number of dying axotomized ganglion cells in the chick embryo. The antioxidant properties of SA are probably responsible for its protective effects, whose U-shaped dose-dependency matches that of several other antioxidants. We conclude that SA protects axotomized neurons by maintaining the redox status near an optimal set-point.


Subject(s)
Antioxidants/pharmacology , Axotomy , Neuroprotective Agents/pharmacology , Retinal Ganglion Cells/drug effects , Salicylic Acid/pharmacology , Animals , Chick Embryo , Dose-Response Relationship, Drug
5.
Brain Res ; 826(2): 181-92, 1999 May 01.
Article in English | MEDLINE | ID: mdl-10224295

ABSTRACT

We have previously demonstrated that mild traumatic brain injury (TBI) of the right parietal cortex results in a relatively selective deficit in conditioned fear responding. However, this behavioural deficit is very consistent and unrelated to the extent of the cortical necrotic lesion. We were therefore interested in determining if other brain regions might show a consistent response to mild TBI, and therefore, more reliably relate to the behavioural change. Increased expression of inducible transcription factors (ITFs) has been used to study which brain regions respond to a variety of events. In the present study, we examined the expression patterns of immunoreactivity (IR) for four ITFs (c-Fos, c-Jun, JunB, and Krox-24) at 3 h after mild fluid percussion TBI. Changes in ITF expression were only observed ipsilateral to the side of TBI. The clearest changes were observed in brain regions known to be involved in conditioned fear responding, such as the amygdala complex and hippocampal formation and several cortical regions. In contrast, no changes in IR for any of the ITFs were observed in the striatum, nucleus accumbens, nucleus basalis magnocellularis, septum or periacqueductal grey. Unlike the extent of visible damage to the cortex at the site of impact, the overexpression of ITFs showed a notable consistency between animals subjected to TBI. This consistency in regions known to be involved in conditioned fear responding (i.e., amygdala complex and hippocampal formation) lead us to suggest that it is these changes, rather than the more variable cortical necrotic lesion, that is responsible for the behavioural deficits we observe following mild TBI. Importantly, our results demonstrate that like the hippocampus, the amygdala is a sub-cortical structure particularly sensitive to the effects of mild brain trauma and underline the fact that cerebral regions distant from the location of the fluid impact can be affected.


Subject(s)
Brain Injuries/metabolism , DNA-Binding Proteins/analysis , Fear/physiology , Immediate-Early Proteins , Proto-Oncogene Proteins c-fos/analysis , Proto-Oncogene Proteins c-jun/analysis , Transcription Factors/analysis , Amygdala/chemistry , Amygdala/physiology , Animals , Antibodies , Behavior, Animal/physiology , Brain Injuries/physiopathology , Conditioning, Psychological/physiology , DNA-Binding Proteins/immunology , Early Growth Response Protein 1 , Genes, Immediate-Early/physiology , Hippocampus/chemistry , Hippocampus/physiology , Male , Parietal Lobe/chemistry , Parietal Lobe/injuries , Parietal Lobe/physiology , Proto-Oncogene Proteins c-fos/immunology , Proto-Oncogene Proteins c-jun/immunology , Rats , Rats, Sprague-Dawley , Transcription Factors/immunology
6.
Exp Neurol ; 155(2): 243-51, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10072299

ABSTRACT

We have studied the effect of lysine acetylsalicylate (LAS; Aspegic), a soluble salt of aspirin, on motor deficits in transgenic mice expressing a human superoxide dismutase SOD1 mutation (Gly-93 --> Ala), an animal model of familial amyotrophic lateral sclerosis (FALS). In nontreated FALS mice, motor impairments appear at 12-14 weeks of age, whereas paralysis is not observed before 20 weeks of age. Life expectancy is 140-170 days. Early treatment with LAS from 5 weeks of age delayed the appearance of motor deficits in FALS mice as measured by extension reflex, loaded grid, and rotarod tests. This beneficial effect of treatment was maintained up to 18 weeks of age, until just before onset of end-stage disease. When treatment was started at 13 weeks, no significant beneficial effect was observed. These results demonstrate that chronic LAS treatment is able to delay the appearance of reflex, coordination, and muscle strength deficits in this animal model of ALS if the treatment is started early enough. However, neither the onset of paralysis nor end-stage disease were improved by the LAS treatment. In the absence of an effect on survival, the functional improvement demonstrated here is probably the maximum that this demanding model could allow. Although other properties of LAS may have contributed to its beneficial effect, we suggest that the antioxidant properties of aspirin are responsible for the positive effects in this model and support the use of antioxidants as effective therapy for ALS.


Subject(s)
Amyotrophic Lateral Sclerosis/drug therapy , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Aspirin/analogs & derivatives , Lysine/analogs & derivatives , Motor Activity/drug effects , Amyotrophic Lateral Sclerosis/genetics , Amyotrophic Lateral Sclerosis/physiopathology , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics , Aspirin/administration & dosage , Aspirin/pharmacokinetics , Aspirin/pharmacology , Body Weight/drug effects , Brain/metabolism , Humans , Lysine/administration & dosage , Lysine/pharmacokinetics , Lysine/pharmacology , Male , Mice , Mice, Transgenic , Muscle, Skeletal/drug effects , Muscle, Skeletal/physiopathology , Mutation , Postural Balance/drug effects , Reflex/drug effects , Salicylates/metabolism , Solubility , Superoxide Dismutase/deficiency , Superoxide Dismutase/genetics
7.
Neuroreport ; 9(13): 3097-101, 1998 Sep 14.
Article in English | MEDLINE | ID: mdl-9804323

ABSTRACT

The molecular composition of the nicotinic acetylcholine receptors (nAChRs) located on dopaminergic neurons and modulating their activity is unclear. Using the reverse transcriptase-polymerase chain reaction we have analyzed the mRNA for nAChR subunits expressed in the substantia nigra (SN) and ventral tegmental area (VTA) following unilateral 6-hydroxydopamine lesion of the dopaminergic system. In contrast to the unlesioned hemisphere, no signal was found in the lesioned hemisphere for alpha3, alpha5, alpha6 and beta4 subunits in the SN nor for alpha2, alpha3, alpha5, alpha6, alpha7 and beta4 subunits in the VTA, indicating the expression of these subunits in dopaminergic neurons. mRNA for alpha4, beta2 and beta3 subunits (and alpha7 in the SN) were still detected after lesion, suggesting that they are expressed in GABAergic neurons and interneurons of these brain areas. These results demonstrate the selective localisation of a number of nAChR subunit mRNA within dopaminergic neurons, strongly suggesting that a heterogenous population of nAChRs play a role in modulating dopaminergic neuronal activity.


Subject(s)
Neurons/chemistry , RNA, Messenger/biosynthesis , Receptors, Nicotinic/genetics , Substantia Nigra/chemistry , Ventral Tegmental Area/chemistry , Animals , Dopamine/metabolism , Drug Administration Routes , Female , Injections , Medial Forebrain Bundle/drug effects , Neurons/cytology , Oxidopamine/administration & dosage , Oxidopamine/pharmacology , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Receptors, Nicotinic/analysis , Reverse Transcriptase Polymerase Chain Reaction
8.
J Neurotrauma ; 15(7): 545-53, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9674557

ABSTRACT

We have previously demonstrated that a lateral fluid percussion-induced traumatic lesion of the right parietal cortex can lead to a deficit in a conditioned freezing response and that this deficit can be attenuated by both pre- and postlesion administration of the NMDA receptor antagonist dizocilpine. In the present study, we investigated the effects of eliprodil, a noncompetitive NMDA receptor antagonist acting at the polyamine modulatory site, which also acts as a Ca2+ channel blocker, on the trauma-induced conditioned freezing deficit. Eliprodil produced a 50% reduction in this deficit when administered as three 1 mg/kg injections i.v. at 15 min, 6 h, and 24 h following the lesion. Approximately the same degree of protection was afforded when 2 x 1.5 mg/kg were administered 6 and 24 h and equally at 12 and 24 h after surgery (56% and 59%, respectively). A single treatment (3 mg/kg) at 24 h was ineffective against the deficit. The protection afforded with treatment at 6 and 24 h after lesion was dose dependent, with a minimal active dose of 2 x 0.75 mg/kg. These data complement those previously published on the ability of eliprodil to reduce lesion volume following traumatic brain injury and show, in addition, that the neuroprotective effect has functional consequences.


Subject(s)
Brain Injuries/drug therapy , Cognition Disorders/prevention & control , Conditioning, Classical/drug effects , Neuroprotective Agents/pharmacology , Parietal Lobe/injuries , Piperidines/pharmacology , Analysis of Variance , Animals , Brain Injuries/complications , Cognition Disorders/etiology , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Administration Schedule , Fear/physiology , Male , Parietal Lobe/drug effects , Parietal Lobe/physiopathology , Rats , Rats, Sprague-Dawley , Time Factors , Time and Motion Studies
9.
Neuroscience ; 84(1): 213-21, 1998 May.
Article in English | MEDLINE | ID: mdl-9522375

ABSTRACT

Functional recovery following a complete unilateral lesion of the nigrostriatal pathway in adult rats was studied. We examined the effect of training on the spontaneous or induced postural bias following the lesion. Two tasks measuring lateralization were used to assess the lesion-induced postural bias: spontaneous asymmetry was evaluated in the Y-maze, whereas induced body bias was measured by hanging the rat by its tail. Recovery was assessed at three different times following the lesion. The effects of lesion in adult rats in the short, medium and long term were evaluated and compared with the effects of dopaminergic transplants. In adult lesioned rats, destruction of dopaminergic innervation of the neostriatum induced initially an ipsilateral bias as measured in the "tail hang test" and the Y-maze. Recovery of function was observed in the tail hang test as ipsilateral bias declined on repeated testing. Apart from this effect, there was a post-lesion interval effect, since the postural bias disappeared more rapidly on repeated testing in the long-term lesioned rats. This spontaneous recovery was impaired by intrastriatal dopaminergic grafts. Furthermore, no spontaneous recovery was observed in the Y-maze test. These observations show that repeated testing can influence the long-term effects of damage to the nigrostriatal dopamine system.


Subject(s)
Behavior, Animal/physiology , Dopamine/metabolism , Mesencephalon/physiology , Animals , Corpus Striatum/drug effects , Corpus Striatum/physiology , Functional Laterality/physiology , Immunohistochemistry , Male , Maze Learning/physiology , Mesencephalon/cytology , Mesencephalon/embryology , Neurons/metabolism , Neurons/transplantation , Oxidopamine/pharmacology , Posture/physiology , Rats , Rats, Inbred Strains , Stereotyped Behavior/physiology , Substantia Nigra/drug effects , Substantia Nigra/physiology , Tyrosine 3-Monooxygenase/metabolism
10.
Neuroreport ; 8(13): 2861-5, 1997 Sep 08.
Article in English | MEDLINE | ID: mdl-9376520

ABSTRACT

We have evaluated the G1H line of transgenic mice overexpressing a familial ALS mutation of SOD1 (Gly-93-->Ala) in tasks assessing different aspects of motor function to determine how early these deficits could be detected and their order of appearance. The earliest deficits were observed in tests of muscle strength and coordination as early as 8 weeks of age and their development appeared to be biphasic, whereas spontaneous activity was not impaired until 15 weeks of age. These studies show that, in addition to the previously demonstrated histological and electromyographic deficits, this transgenic mouse also presents changes in motor function reminiscent of the human disease, reinforcing and extending its validity as an animal model of familial amyotrophic lateral sclerosis (FALS) and allowing the investigation of novel drug treatment for ALS.


Subject(s)
Amyotrophic Lateral Sclerosis/genetics , Point Mutation , Psychomotor Performance/physiology , Superoxide Dismutase/genetics , Animals , Cell Death/physiology , Disease Models, Animal , Electromyography , Evaluation Studies as Topic , Humans , Longitudinal Studies , Mice , Mice, Transgenic , Neurons/pathology
11.
Neuroscience ; 74(4): 971-83, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8895866

ABSTRACT

The aim of the present study was to analyse whether riluzole, a compound that interacts with the voltage-dependent sodium channel and impairs glutamatergic transmission, would exhibit a neuroprotective activity in a model of Parkinson's disease in the rat. Impaired skilled forelimb use, circling behavior, and altered dopaminergic metabolism of the mesotelencephalic system were evaluated in unilaterally 6-hydroxydopamine-lesioned rats. Riluzole was administered twice 15 min before, and 24 h after, the lesion. Riluzole reduced both the contralateral rotations induced by apomorphine and the ipsilateral ones elicited by amphetamine. Moreover, the decreased dopaminergic metabolism seen after 6-hydroxydopamine injection was attenuated in the riluzole-treated animals, at both the striatal and nigral levels. These biochemical and behavioral results demonstrate the ability of riluzole partially to protect the degeneration of the nigrostriatal dopaminergic neurons induced by the toxin 6-hydroxydopamine. Perhaps, the most striking evidence for the protective effect of riluzole was that this compound improved the skilled paw use, a complex sensorimotor behavior which is not easily ameliorated by palliative therapies such as dopaminergic grafts. These results extend previous data showing that riluzole counteracts the toxicity induced by 1-methyl-4-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium in rodent dopaminergic neurons. The use of riluzole may be considered of potential interest for the neuroprotective therapy of Parkinson's disease.


Subject(s)
Neuroprotective Agents/therapeutic use , Parkinson Disease, Secondary/drug therapy , Thiazoles/therapeutic use , 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine , Amphetamine/pharmacology , Animals , Apomorphine/pharmacology , Brain Chemistry/drug effects , Central Nervous System Stimulants/pharmacology , Conditioning, Operant/drug effects , Dopamine Agonists/pharmacology , Female , Male , Oxidopamine , Parkinson Disease, Secondary/chemically induced , Parkinson Disease, Secondary/metabolism , Rats , Rats, Inbred Strains , Riluzole , Stereotyped Behavior/drug effects , Substantia Nigra/drug effects , Substantia Nigra/metabolism , Substantia Nigra/physiology , Sympatholytics
12.
Neurobiol Dis ; 3(1): 76-86, 1996 Feb.
Article in English | MEDLINE | ID: mdl-9173915

ABSTRACT

Gene therapy in the nervous system offers an attractive strategy for the administration of therapeutic factors in a potentially region-specific, sustained, and well-tolerated manner. We tested the trophic effect of a recombinant adenovirus encoding nerve growth factor (AdNGF) in vivo on basal forebrain cholinergic neurons of aged rats, a neuronal population affected during normal and pathological aging. Three weeks after unilateral injection of the recombinant adenovirus into the nucleus basalis magnocellularis, a significant increase in the somal areas of cholinergic neurons ipsilateral to the injection was observed. No increase was detected in animals receiving a recombinant adenovirus carrying the Escherichia coli Lac Z reporter gene. Injected animals did not lose weight, an adverse effect usually described after intracerebroventricular infusion of NGF, and no tissue loss or massive local inflammatory response was observed around injection sites. Thus, a single intracerebral injection of AdNGF produces trophic effects similar to those resulting from chronic intracerebroventricular high levels of NGF. These findings indicate that recombinant adenoviruses encoding growth factors are potentially powerful tools for improving neuronal deficits associated with degenerative processes.


Subject(s)
Acetylcholine/analysis , Adenoviruses, Human/genetics , Aging/pathology , Basal Ganglia/pathology , Genetic Vectors/genetics , Nerve Growth Factors/physiology , Neurons/pathology , Transfection , Animals , Cell Size , Cells, Cultured , Genes, Reporter , Genetic Vectors/administration & dosage , HeLa Cells , Humans , Injections , Male , Nerve Growth Factors/genetics , PC12 Cells , Rats , Substantia Innominata
13.
Neuroscience ; 67(4): 837-48, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7675209

ABSTRACT

This study compares certain behavioural consequences of partial and complete unilateral lesions of the dopaminergic mesotelencephalic system. We investigated skilled forelimb use, rotations induced by apomorphine and amphetamine, and dopaminergic metabolism of the nigrostriatal system of rats that had received a unilateral injection of 6-hydroxydopamine into the medial forebrain bundle. The rats classified Apo(+), that rotated after the administration of apomorphine, had a complete lesion of the nigrostriatal system, whereas those classified Apo(-), that did not rotate after the administration of apomorphine, had a partial lesion of the nigrostriatal system. In the Apo(+) rats, 99.8% of the dopamine in the striatum was depleted, as was 85% of that in the substantia nigra. For the Apo(-) rats, 72% of the dopamine in the striatum was depleted as was 56% of that in the substantia nigra. When investigated with the staircase test, the animals with the most severe dopamine depletions were those most impaired in the paw reaching task. Complete and partial unilateral depletions of the dopaminergic mesotelencephalic system impaired the hierarchic phases of paw reaching differently. A complete dopamine depletion, but not a partial one, decreased the number of attempts made with the contralateral paw, and induced a bias towards the ipsilateral paw. A partial dopamine lesion impaired the sensorimotor co-ordination of both paws, whereas the complete dopamine lesion had a greater effect on the contralateral paw than on the ipsilateral paw. The mild paw reaching impairments observed in animals with moderate depletions of dopamine are proposed as a model of the early symptoms of Parkinson's disease that may be useful for the development of protective or restorative therapies.


Subject(s)
Dopamine/metabolism , Forelimb/physiology , Animals , Apomorphine/pharmacology , Behavior, Animal , Disease Models, Animal , Parkinson Disease , Rats , Rats, Inbred Strains , Rotation
15.
Neuroreport ; 6(1): 49-53, 1994 Dec 30.
Article in English | MEDLINE | ID: mdl-7703427

ABSTRACT

Direct intracerebral gene transfer to neural cells has been demonstrated with recombinant adenovirus encoding beta-galactosidase. To explore the potential of recombinant adenovirus for the therapy of neurological disease we constructed a recombinant adenovirus encoding tyrosine hydroxylase and optimized intracerebral injection to express the gene in the striatum of unilaterally denervated rats. These animals have dopamine depletion in their lesioned striatum, causing a rotation asymmetry induced by apomorphine. One and two weeks after intracerebral injection this sensorimotor asymmetry was decreased by the adenovirus encoding tyrosine hydroxylase and not by a control adenovirus encoding beta-galactosidase. Histological analysis showed that tyrosine hydroxylase was preferentially expressed in astrocytes.


Subject(s)
Adenoviridae/physiology , Brain/physiopathology , Gene Transfer Techniques , Parkinson Disease/therapy , Tyrosine 3-Monooxygenase/genetics , Animals , Apomorphine/pharmacology , Behavior, Animal/drug effects , Corpus Striatum/drug effects , Denervation , Female , Genetic Vectors , Oxidopamine/pharmacology , Parkinson Disease/genetics , Rats , Rats, Sprague-Dawley , Recombination, Genetic , Stereotyped Behavior , beta-Galactosidase/genetics
16.
Learn Mem ; 1(3): 153-64, 1994.
Article in English | MEDLINE | ID: mdl-10467593

ABSTRACT

We have previously reported that CCK-A receptor agonists and CCK-B receptor antagonists both enhance memory in an olfactory recognition test. Here, we report that the memory-enhancing effect of the CCK-B receptor antagonist L-365,260 (1 mg/kg i.p.), but not that of the CCK-A receptor agonist caerulein (0.03 mg/kg i.p.), was dramatically decreased following a bilateral transection of the perforant path, a principal source of input to the hippocampal formation. We further confirmed that a significant memory deficit occurred subsequent to this deafferentation of the hippocampus in untreated animals. In contrast, the effect of caerulein, but not that of L-365,260, was abolished following a bilateral subdiaphragmatic vagotomy. These results demonstrate that the hippocampal system plays a role in olfactory recognition and indicate that distinct neuronal pathways underlie the memory-enhancing effects of CCK-A and CCK-B drugs observed in the olfactory recognition test. The former effects (CCK-A) appear to involve a peripheral relay to the brain via the vagus nerve, whereas the latter (CCK-B) are directly central and involve, at least in part, the hippocampal system.


Subject(s)
Cognition/physiology , Olfactory Pathways/physiology , Receptors, Cholecystokinin/physiology , Smell/physiology , Animals , Cognition/drug effects , Male , Olfactory Pathways/drug effects , Rats , Rats, Wistar , Receptor, Cholecystokinin A , Receptor, Cholecystokinin B , Receptors, Cholecystokinin/agonists , Smell/drug effects , Stimulation, Chemical , Vagotomy
17.
Behav Brain Res ; 62(2): 157-64, 1994 Jun 30.
Article in English | MEDLINE | ID: mdl-7945966

ABSTRACT

We studied the influence of vision on the expression of handedness in mice. In one experiment we submitted adult mice that had an opaque scleral contact lens fitted to one eye, to a paw-preference testing procedure. When the eye was occluded before training, the animals showed a clear preference for the paw ipsilateral to the open eye; however, we could not induce a shift in a previously determined, natural, paw-preference when the lens was placed over the eye ipsilateral to the spontaneously preferred paw; these results indicate that vision plays a role in the animal's choice of a paw during the learning phase of the paw-preference test. In a second experiment adult mice that had been subjected to unilateral eye removal at birth, underwent the same test. The enucleation did not appear to influence handedness with respect to both direction and strength. The latter result--we propose--reflects a reorganization of the visual system induced by neonatal enucleation.


Subject(s)
Attention/physiology , Functional Laterality/physiology , Psychomotor Performance/physiology , Sensory Deprivation/physiology , Animals , Animals, Newborn , Female , Male , Mice , Mice, Inbred Strains , Neuronal Plasticity/physiology , Visual Pathways/physiology
18.
Proc Natl Acad Sci U S A ; 90(8): 3246-50, 1993 Apr 15.
Article in English | MEDLINE | ID: mdl-8475066

ABSTRACT

Studies on the role of heredity in the transmission of handedness in nonhuman mammals have, so far, led to the isolation of mouse strains that differed in the lateralized versus ambidextrous use of the forepaw in a food-retrieval task (strength of paw preference). Here we report that left versus right use of the forepaw (direction of paw preference) is associated with a genetically expressed structural asymmetry of a sensory system, the whisker-to-barrel pathway. Mice that express whisker pad asymmetry of a direction that corresponds with the asymmetry for which they were bred demonstrate an opposite shift in the distribution of handedness: a right or left dominance of the whisker pad predicts a high proportion of left-handers or right-handers, respectively. Is an altered brain circuit--that is, a consequence of the asymmetry of the whisker pad--associated with a change in the circuitry that governs handedness? Or, alternatively, are there two gene sets responsible for the phenomena that we report--one that causes "whiskeredness" and another that causes handedness?


Subject(s)
Cerebral Cortex/physiology , Forelimb/innervation , Functional Laterality/genetics , Mice, Inbred Strains/physiology , Vibrissae/innervation , Animals , Mice , Mice, Inbred Strains/genetics , Species Specificity
19.
Behav Brain Res ; 44(1): 87-99, 1991 Jul 01.
Article in English | MEDLINE | ID: mdl-1910574

ABSTRACT

Knowing that the mystacial vibrissae are an important part of the tactile sensory apparatus of rodents, we investigated the role of the barrel cortex - the endstation of the pathway between whiskerpad and cerebral cortex - in mouse behavior. We tested 15 female adult mice 2 and 10 weeks after both unilateral ablation of the barrel cortex and removal of the vibrissae on the same side in order to assess acute as well as transient effects of the cortical lesion. Two kinds of behavioral tests were performed on animals permanently provided with opaque lenses: one involved a passive stimulation of the vibrissae; the other was the 'gap-crossing' test which required the animal's active use of the vibrissae. Lesioned subjects did not show a deficit during passive stimulation of the vibrissae. On the contrary, there was a deficit during the gap-crossing test 2 weeks after the ablation of the barrel cortex. The deficit partly disappeared when the subjects were tested 10 weeks later. The results show that in mice, the barrel cortex is involved in the performance of complex behavioral tasks. The recovery of function could be due to changes in strategies to solve the gap-crossing test and/or to physical changes in neuronal circuitry. In either case, the results are relevant for the interpretation of cortical transplantation models using the whisker-to-barrel pathway.


Subject(s)
Behavior, Animal/physiology , Cerebral Cortex/physiology , Vibrissae/physiology , Animals , Cerebral Cortex/anatomy & histology , Female , Functional Laterality , Mice , Mice, Inbred Strains , Physical Stimulation , Vision, Ocular/physiology
20.
Brain Res ; 550(1): 125-8, 1991 May 31.
Article in English | MEDLINE | ID: mdl-1888989

ABSTRACT

Brain immunomodulation may be lateralized as evidenced by two experimental approaches. Using a behavioral paradigm, we have reported an association between asymmetrical brain function and lymphocyte reactivity in mice selected for right- and left-paw preference. Left-handed mice, in comparison to right-handers, exhibit higher mitogen-induced T-lymphocyte proliferation. Using a cortical lesion paradigm in mice, it has been previously shown that each hemicortex modulates in opposite directions lymphocyte reactivity. In these experiments, the role of the brain cortex in the association between paw preference and immune reactivity was assessed by studying mitogen-induced lymphoproliferation in left- and right-handed mice after right or left-cortical ablation. The difference in T-lymphocyte responsiveness between right- and left-handed mice persisted after right lesions but was abolished after left lesions. This immunological effect of left cortical ablation is hypothesized to involve the hypothalamic dopaminergic neurons.


Subject(s)
Cerebral Cortex/physiology , Functional Laterality , Lymphocyte Activation , T-Lymphocytes/immunology , Analysis of Variance , Animals , Cerebral Cortex/immunology , Female , Mice , Mice, Inbred C3H , Mitogens , Reference Values , Spleen/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...